The first monoclonal antibody for cancer

    The FDA just approved the first monoclonal antibody for cancer...Rituxan (rituximab) from Genentech.

    Rituxan is approved for certain cases of B-cell lymphoma...a malignancy of the antibody-producing B-cells.

    Rituxan binds to these malignant cells...allowing the immune system to recognize and eliminate them.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote